Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1Gastrointestinal 1Dermatologic 1CNS 1Breast 1

Conditions

Breast Neoplasms 8Triple Negative Breast Neoplasms 2Squamous Cell Carcinoma of Head and Neck 1Small Cell Lung Carcinoma 1Ovarian Neoplasms 1Melanoma 1Head and Neck Neoplasms 1Gastrointestinal Neoplasms 1Fallopian Tube Neoplasms 1Central Nervous System Neoplasms 1Carcinoma, Non-Small-Cell Lung 1

Interventions

selpercatinib 2Trastuzumab 2Paclitaxel 2sodium thiosulfate 1pazopanib 1glutathione pegylated liposomal doxorubicin 1fluoroacetic acid 1elacestrant 1durvalumab 1carboxyamido-triazole 1abemaciclib 1Temozolomide 1Taxes 1Surveys and Questionnaires 1RAD1901 1Quality of Life 1Patient Reported Outcome Measures 1Molecular Diagnostic Techniques 1Methotrexate 1Magnetic Resonance Spectroscopy 1MLN 8237 1Levofloxacin 1Lapatinib 1Immunotherapy 1Immunoenzyme Techniques 1Genetic Testing 1Genetic Counseling 1Gemcitabine 1Drug Therapy 1D-methadone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Central Nervous System Neoplasms × MLN 8237 × Breast × Clear all
NCT01639911 2019-07-22

Phase I Study of MLN8237 and Pazopanib in Patients With Solid Tumors

University of Illinois at Chicago

Phase 1 Completed
28 enrolled
BreastCNSDermatologicGastrointestinalHead & Neck

Breast Neoplasms, Gastrointestinal Neoplasms, Head and Neck Neoplasms, Melanoma, Central Nervous System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡